SI-BONE, Inc. Common Stock (SIBN)
SI-BONE, Inc. is a medical device company specializing in minimally invasive solutions for the treatment of musculoskeletal disorders of the sinonasal and sacroiliac joint regions. The company develops and commercializes products designed to improve patient outcomes by addressing conditions related to the pelvis and sacroiliac joint, with a focus on innovative, image-guided procedures.
Company News
SI-Bone reported a data breach on October 1, 2025, potentially exposing sensitive personal information including names, Social Security numbers, and medical details. A law firm is investigating potential legal action on behalf of affected customers.
Four under-the-radar companies - Porch Group, SunOpta, Tutor Perini, and Si-Bone - reported strong earnings in Q1 2025 and are seeing positive momentum in May.
Inogen is well-positioned for growth in the portable oxygen concentrator (POC) market, with a strong product portfolio and solid Q2 results. However, it faces stiff competition and forex volatility. The company's stock has outperformed the industry and the S&P 500 year-to-date.
Si-Bone (SIBN) delivered earnings and revenue surprises of 6.90% and 3.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
The company reported first-quarter earnings and improved revenue guidance.